Vaccines
Japanese ecephalitis vaccine
Vaccines
Other names: Ixiaro
FAA guidance
Acceptable in the FAA document cited.
The FAA's MedGuide lists Japanese ecephalitis vaccine (Ixiaro) as allowed, for immunization, with no wait after the first dose, after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: Japanese ecephalitis vaccineThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
Show the FAA's words: Japanese ecephalitis vaccineThe official FAA wording: three passages, each with its document and dateOpen
Generic: Japanese ecephalitis vaccine
Brand Name: Ixiaro
Drug Class: Vaccines
Underlying Condition: Immunization
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.